PyInvesting

Market research

002365.SHE Qianjiang Yongan Pharmaceutical Co., Ltd

SHE CNY Healthcare

Latest close

12.23 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
62.11
Analyst target
18.9
Dividend yield
0.8%
Beta
0.32

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Qianjiang Yongan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 3.3% below its 200 day moving average.

From a valuation standpoint, the stock is 77.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.

Qianjiang Yongan Pharmaceutical Co., Ltd's total revenue sank by 21.9% to $281M since the same quarter in the previous year.

Its net income has dropped by 145.2% to $-9M since the same quarter in the previous year.

Finally, its free cash flow fell by 10.9% to $60M since the same quarter in the previous year.

Based on the above factors, Qianjiang Yongan Pharmaceutical Co., Ltd gets an overall score of 1/5.